Phase I and pharmacokinetic study of the oral farnesyl transferase inhibitor SCH 66336 given twice daily to patients with advanced solid tumors (Q31960434)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q132042279)
(P304) 1167-1175
(P407) (Q1860)
(P433) 4
(P478) 19
(P577) Thursday, February 1, 2001
(P921) (Q323936)
(P1433) (Q400292)
(P1476) "Phase I and pharmacokinetic study of the oral farnesyl transferase inhibitor SCH 66336 given twice daily to patients with advanced solid tumors" (language: en)
(P2093) A Awada
D L Cutler
M J de Jonge
G P Luyten
M N Faber
P Statkevich
A Sparreboom
J Verweij
A R Hanauske
M Piccart
European Organization for Research and Treatment of Cancer Early Clinical Studies Group
other details
description scientific article

External Links